MRMaría Teresa Ramírez-Apan

María Teresa Ramírez-Apan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


María Teresa Ramírez-Apan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Antiproliferative Activity and NO Inhibition of Neo-Clerodane Diterpenoids from Salvia guevarae in RAW 264.7 Macrophages

    by Juan Pablo Torres-Médicis, Celia Bustos-Brito, Leovigildo Quijano, Brenda Y. Bedolla-García, Sergio Zamudio, Teresa Ramírez-Apan, Diego Martínez-Otero, Baldomero Esquivel

    In this study, nine neo-clerodane-type diterpenoids (1–9) were isolated from the dichloromethane extract of Salvia guevarae Bedolla & Zamudio leaves. Compounds 1–6 were new natural products, and 7–9 were acetone artifacts. In addition, four neo-clerodanes diterpenoids (10–13) previously described from different sources and six triterpenoids—identified as 3β,20,25-trihydroxylupane, oleanolic acid, 3β-O-acetyl-oleanolic acid, ursolic acid, 3β-O-acetyl-betulinic acid, and 3β,28-O-diacetyl-betulin—were isolated. Additionally, five flavonoids were also isolated from the methanol extract: quercetin-3-O-β-xylopyranosyl-(1 → 2)-β-galactopyranoside, taxifolin-7-O-β-glucopyranoside, naringenin-7-O-β-glucopyranoside, a mixture of 2R and 2S eriodictyol-7-O-β-glucopyranoside, caffeic acid, the methyl ester of rosmarinic acid, and rosmarinic acid. The structure of the isolated compounds was established by spectroscopic means, mainly 1H and 13C NMR, including 1D and 2D homo- and heteronuclear experiments. The absolute configuration of 1 and 10 was ascertained via an X-ray analysis, and that of the other compounds via ECD. The antiproliferative activity of some diterpenoids was determined using the sulforhodamine B method, where guevarain B (2) and 6α-hydroxy-patagonol acetonide (7) showed moderate activity against the K562 line, with IC50 (μM) = 33.1 ± 1.3 and 39.8 ± 1.5, respectively. The NO inhibition in RAW 264.7 macrophage activity was also determined for some compounds, where 2-oxo-patagonal (6), 6α-hydroxy-patagonol acetonide (7), and 7α-acetoxy-ent-clerodan-3,13-dien-18,19:16,15-diolide (10) were proven to be active, with IC50 (μM) of 26.4 ± 0.4, 17.3 ± 0.5, and 13.7 ± 2.0, respectively. The chemotaxonomy of Salvia guevarae is also discussed.


  • Open Access

    Synthesis, Cytotoxic Activity and In Silico Study of Novel Dihydropyridine Carboxylic Acids Derivatives

    by Ricardo Ballinas-Indilí, María Inés Nicolás-Vázquez, Joel Martínez, María Teresa Ramírez-Apan, Cecilio Álvarez-Toledano, Alfredo Toscano, Maricarmen Hernández-Rodríguez, Elvia Mera Jiménez, René Miranda Ruvalcaba

    To aid the possible prevention of multidrug resistance in tumors and cause lower toxicity, a set of sixteen novel dihydropyridine carboxylic acids derivatives 3a–p were produced; thus, the activation of various ynones with triflic anhydride was performed, involving a nucleophilic addition of several bis(trimethylsilyl) ketene acetals, achieving good yields requiring easy workup. The target molecules were unequivocally characterized by common spectroscopic methods. In addition, two of the tested compounds (3a, and 3b) were selected to perform in silico studies due to the highest cytotoxic activity towards the HCT-15 cell line (7.94 ± 1.6 μM and 9.24 ± 0.9 μM, respectively). Employing theoretical calculations with density functional theory (DFT) using the B3LYP/6-311++G(d,p) showed that the molecular parameters correlate adequately with the experimental results. In contrast, predictions employing Osiris Property Explorer showed that compounds 3a and 3b present physicochemical characteristics that would likely make it an orally active drug. Moreover, the performance of Docking studies with proteins related to the apoptosis pathway allowed a proposal of which compounds could interact with PARP-1 protein. Pondering the obtained results (synthesis, in silico, and cytotoxic activity) of the target compounds, they can be judged as suitable antineoplastic agent candidates.


  • Open Access

    Three-Component Synthesis of 2-Amino-3-cyano-4H-chromenes, In Silico Analysis of Their Pharmacological Profile, and In Vitro Anticancer and Antifungal Testing

    by Alberto Feliciano, Omar Gómez-García, Carlos H. Escalante, Mario A. Rodríguez-Hernández, Mariana Vargas-Fuentes, Dulce Andrade-Pavón, Lourdes Villa-Tanaca, Cecilio Álvarez-Toledano, María Teresa Ramírez-Apan, Miguel A. Vázquez, et al.

    Chromenes are compounds that may be useful for inhibiting topoisomerase and cytochrome, enzymes involved in the growth of cancer and fungal cells, respectively. The aim of this study was to synthesize a series of some novel 2-amino-3-cyano-4-aryl-6,7-methylendioxy-4H-chromenes 4a–o and 2-amino-3-cyano-5,7-dimethoxy-4-aryl-4H-chromenes 6a–h by a three-component reaction, and test these derivatives for anticancer and antifungal activity. Compounds 4a and 4b were more active than cisplatin (9) and topotecan (7) in SK-LU-1 cells, and more active than 9 in PC-3 cells. An evaluation was also made of the series of compounds 4 and 6 as potential antifungal agents against six Candida strains, finding their MIC50 to be less than or equal to that of fluconazole (8). Molecular docking studies are herein reported, for the interaction of 4 and 6 with topoisomerase IB and the active site of CYP51 of Candida spp. Compounds 4a–o and 6a–h interacted in a similar way as 7 with key amino acids of the active site of topoisomerase IB and showed better binding energy than 8 at the active site of CYP51. Hence, 4a–o and 6a–h are good candidates for further research, having demonstrated their dual inhibition of enzymes that participate in the growth of cancer and fungal cells.


  • Open Access

    In Vitro Evaluation of the Potential Pharmacological Activity and Molecular Targets of New Benzimidazole-Based Schiff Base Metal Complexes

    by Alberto Aragón-Muriel, Yamil Liscano, Yulieth Upegui, Sara M. Robledo, María Teresa Ramírez-Apan, David Morales-Morales, Jose Oñate-Garzón, Dorian Polo-Cerón

    Metal-based drugs, including lanthanide complexes, have been extremely effective in clinical treatments against various diseases and have raised major interest in recent decades. Hence, in this work, a series of lanthanum (III) and cerium (III) complexes, including Schiff base ligands derived from (1H-benzimidazol-2-yl)aniline, salicylaldehyde, and 2,4-dihydroxybenzaldehyde were synthesized and characterized using different spectroscopic methods. Besides their cytotoxic activities, they were examined in human U-937 cells, primate kidney non-cancerous COS-7, and six other, different human tumor cell lines: U251, PC-3, K562, HCT-15, MCF-7, and SK-LU-1. In addition, the synthesized compounds were screened for in vitro antiparasitic activity against Leishmania braziliensis, Plasmodium falciparum, and Trypanosoma cruzi. Additionally, antibacterial activities were examined against two Gram-positive strains (S. aureus ATCC® 25923, L. monocytogenes ATCC® 19115) and two Gram-negative strains (E. coli ATCC® 25922, P. aeruginosa ATCC® 27583) using the microdilution method. The lanthanide complexes generally exhibited increased biological activity compared with the free Schiff base ligands. Interactions between the tested compounds and model membranes were examined using differential scanning calorimetry (DSC), and interactions with calf thymus DNA (CT-DNA) were investigated by ultraviolet (UV) absorption. Molecular docking studies were performed using leishmanin (1LML), cruzain (4PI3), P. falciparum alpha-tubulin (GenBank sequence CAA34101 [453 aa]), and S.aureus penicillin-binding protein 2a (PBP2A; 5M18) as the protein receptors. The results lead to the conclusion that the synthesized compounds exhibited a notable effect on model membranes imitating mammalian and bacterial membranes and rolled along DNA strands through groove interactions. Interactions between the compounds and studied receptors depended primarily on ligand structures in the molecular docking study.


  • Open Access

    Structure, Absolute Configuration, and Antiproliferative Activity of Abietane and Icetexane Diterpenoids from Salvia ballotiflora

    by Baldomero Esquivel, Celia Bustos-Brito, Mariano Sánchez-Castellanos, Antonio Nieto-Camacho, Teresa Ramírez-Apan, Pedro Joseph-Nathan, Leovigildo Quijano

    From the aerial parts of Salvia ballotiflora, eleven diterpenoids were isolated; among them, four icetexanes and one abietane (1–5) are reported for the first time. Their structures were established by spectroscopic means, mainly 1H- and 13C-NMR, including 1D and 2D homo- and hetero-nuclear experiments. Most of the isolated diterpenoids were tested for their antiproliferative, anti-inflammatory, and radical scavenging activities using the sulforhodamine B assay on six cancer cell lines, the TPA-induced ear edema test in mice, and the reduction of the DPPH assay, respectively. Some diterpenoids showed anti-proliferative activity, these being icetexanes 6 and 3, which were the most active with IC50 (μM) = 0.27 ± 0.08 and 1.40 ± 0.03, respectively, for U251 (human glioblastoma) and IC50 (μM) = 0.0.46 ± 0.05 and 0.82 ± 0.06 for SKLU-1 (human lung adenocarcinoma), when compared with adriamycin (IC50 (μM) = 0.08 ± 0.003 and 0.05 ± 0.003, as the positive control), respectively. Compounds 3 and 10 showed significant reduction of the induced ear edema of 37.4 ± 2.8 and 25.4 ± 3.0% (at 1.0 μmol/ear), respectively. Compound 4 was the sole active diterpenoid in the antioxidant assay (IC50 = 98. 4 ± 3.3), using α-tocopherol as the positive control (IC50 (μM) = 31.7 ± 1.04). The diterpenoid profile found is of chemotaxonomic relevance and reinforces the evolutionary link of S. ballotiflora with other members of the section Tomentellae.


  • Synthesis of new derivatives of 21-imidazolyl-16-dehydropregnenolone as inhibitors of 5α-reductase 2 and with cytotoxic activity in cancer cells

    by Aylin Viviana Silva-Ortiz, Eugene Bratoeff, Teresa Ramírez-Apan, Yvonne Heuze, Juan Soriano, Isabel Moreno, Marisol Bravo, Lucero Bautista, Marisa Cabeza


  • Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line

    by Francisco Cortés-Benítez, Marisa Cabeza, María Teresa Ramírez-Apan, Berenice Alvarez-Manrique, Eugene Bratoeff


  • Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1

    by Aylin Viviana Silva-Ortiz, Eugene Bratoeff, Teresa Ramírez-Apan, Yvonne Heuze, Araceli Sánchez, Juan Soriano, Marisa Cabeza